Delivery Order SPE2DX22D0010-SPE2D825FHF30
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $2,046.80 on June 16, 2025, with an ultimate completion date of June 17, 2025. This competitively awarded, firm fixed-price delivery order covers the supply of AZSTARYS Capsules (39.2mg/7.8mg), a prescription medication used for attention deficit hyperactivity disorder treatment. No set-aside designation was applied to this contract. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a $4,848.20 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for AZSTARYS capsules (39.2mg/7.8mg), a prescription medication used in the treatment of attention-deficit/hyperactivity disorder. This firm fixed price, non-set-aside contract is scheduled for completion by September 12, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single...
- On September 10, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,414.27 to AmerisourceBergen Drug Corp for Azstarys capsules (52.3mg/10.4mg), a prescription medication used in the treatment of attention deficit hyperactivity disorder. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The work will be performed at the contractor's corporate office location in Conshohocken,...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,169.97 contract is for the supply of AZSTARYS capsules, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,313.06 to AmerisourceBergen Drug Corp for AZSTARYS 26.1 mg-5.2 mg capsules (100-count supply). This firm fixed price, non-set-aside delivery order was awarded on June 30, 2025, with an ultimate completion date of July 1, 2025. The contract represents a standard pharmaceutical procurement under the Defense Logistics Agency's medical supply operations, with performance taking place at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,719.10 to AmerisourceBergen Drug Corp for AZSTARYS 26.1 mg-5.2 mg capsules (100-count package) on March 5, 2025. This competitive award, which carries an ultimate completion date of March 6, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $4,782.29 to AmerisourceBergen Drug Corp for AZSTARYS 39.2 mg-7.8 mg capsules (100-count) on August 19, 2025, with completion scheduled for August 20, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a $3,332.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AZSTARYS 52.3 mg-10.4 mg capsules (100-count supply) on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- This delivery order, valued at $1,436.84, awards AmerisourceBergen Drug Corp a competitively awarded, firm fixed-price contract for the supply of Azstarys 39.2 mg-7.8 mg capsules (100-count units) effective through September 16, 2025. The award was made by the Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical procurement to support military and veteran healthcare systems. The contract carries no set-aside designation, indicating open competition among eligible...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,370.10 firm fixed price delivery order for Azstarys 39.2 mg-7.8 mg capsules (100-count) on August 7, 2025, with completion scheduled for August 8, 2025. This non-set-aside contract represents a single delivery under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHF30Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a $3,853.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AZSTARYS CAPS 52.3MG/10.4MG, a prescription medication used primarily for attention-deficit/hyperactivity disorder treatment. Issued on July 28, 2025, with a completion date of July 29, 2025, this competitively awarded contract required no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, continues to serve as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This comprehensive vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to fulfill federal medical supply requirements through competitive procurement and its established position as a pharmaceutical prime vendor underscores its significance within the Defense Department's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 7/28/25 |